Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease

Keng Gat Lim, Alexander I. Gray, Nahoum G. Anthony, Simon P. MacKay, Susan Pyne, Nigel J. Pyne

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Resveratrol, a natural compound endowed with multiple health-promoting effects, has received much attention given its potential for the treatment of cardiovascular, inflammatory, neurodegenerative, metabolic and age-related diseases. However, the translational potential of resveratrol has been limited by its specificity, poor bioavailability and uncertain toxicity. In recent years, there has been an accumulation of evidence demonstrating that resveratrol modulates sphingolipid metabolism. Moreover, resveratrol forms higher order oligomers that exhibit better selectivity and potency in modulating sphingolipid metabolism. This review evaluates the evidence supporting the modulation of sphingolipid metabolism and signaling as a mechanism of action underlying the therapeutic efficacy of resveratrol and oligomers in diseases, such as cancer.
LanguageEnglish
Pages2213-2232
Number of pages20
JournalArchives of Toxicology
Volume88
Issue number12
Early online date25 Oct 2014
DOIs
Publication statusPublished - 25 Oct 2014

Fingerprint

Sphingolipids
Oligomers
Metabolism
Modulation
Biological Availability
Toxicity
resveratrol
Health
Neoplasms

Keywords

  • resveratrol oligomers
  • resveratrol
  • sphingolipid
  • disease
  • cancer
  • drug discovery

Cite this

@article{ba4d761ce3784be8b64e6230168995b9,
title = "Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease",
abstract = "Resveratrol, a natural compound endowed with multiple health-promoting effects, has received much attention given its potential for the treatment of cardiovascular, inflammatory, neurodegenerative, metabolic and age-related diseases. However, the translational potential of resveratrol has been limited by its specificity, poor bioavailability and uncertain toxicity. In recent years, there has been an accumulation of evidence demonstrating that resveratrol modulates sphingolipid metabolism. Moreover, resveratrol forms higher order oligomers that exhibit better selectivity and potency in modulating sphingolipid metabolism. This review evaluates the evidence supporting the modulation of sphingolipid metabolism and signaling as a mechanism of action underlying the therapeutic efficacy of resveratrol and oligomers in diseases, such as cancer.",
keywords = "resveratrol oligomers, resveratrol, sphingolipid , disease, cancer, drug discovery",
author = "Lim, {Keng Gat} and Gray, {Alexander I.} and Anthony, {Nahoum G.} and MacKay, {Simon P.} and Susan Pyne and Pyne, {Nigel J.}",
year = "2014",
month = "10",
day = "25",
doi = "10.1007/s00204-014-1386-4",
language = "English",
volume = "88",
pages = "2213--2232",
journal = "Archives of Toxicology",
issn = "0340-5761",
number = "12",

}

Resveratrol and its oligomers : modulation of sphingolipid metabolism and signaling in disease. / Lim, Keng Gat; Gray, Alexander I.; Anthony, Nahoum G.; MacKay, Simon P.; Pyne, Susan; Pyne, Nigel J.

In: Archives of Toxicology, Vol. 88, No. 12, 25.10.2014, p. 2213-2232.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Resveratrol and its oligomers

T2 - Archives of Toxicology

AU - Lim, Keng Gat

AU - Gray, Alexander I.

AU - Anthony, Nahoum G.

AU - MacKay, Simon P.

AU - Pyne, Susan

AU - Pyne, Nigel J.

PY - 2014/10/25

Y1 - 2014/10/25

N2 - Resveratrol, a natural compound endowed with multiple health-promoting effects, has received much attention given its potential for the treatment of cardiovascular, inflammatory, neurodegenerative, metabolic and age-related diseases. However, the translational potential of resveratrol has been limited by its specificity, poor bioavailability and uncertain toxicity. In recent years, there has been an accumulation of evidence demonstrating that resveratrol modulates sphingolipid metabolism. Moreover, resveratrol forms higher order oligomers that exhibit better selectivity and potency in modulating sphingolipid metabolism. This review evaluates the evidence supporting the modulation of sphingolipid metabolism and signaling as a mechanism of action underlying the therapeutic efficacy of resveratrol and oligomers in diseases, such as cancer.

AB - Resveratrol, a natural compound endowed with multiple health-promoting effects, has received much attention given its potential for the treatment of cardiovascular, inflammatory, neurodegenerative, metabolic and age-related diseases. However, the translational potential of resveratrol has been limited by its specificity, poor bioavailability and uncertain toxicity. In recent years, there has been an accumulation of evidence demonstrating that resveratrol modulates sphingolipid metabolism. Moreover, resveratrol forms higher order oligomers that exhibit better selectivity and potency in modulating sphingolipid metabolism. This review evaluates the evidence supporting the modulation of sphingolipid metabolism and signaling as a mechanism of action underlying the therapeutic efficacy of resveratrol and oligomers in diseases, such as cancer.

KW - resveratrol oligomers

KW - resveratrol

KW - sphingolipid

KW - disease

KW - cancer

KW - drug discovery

UR - http://www.scopus.com/inward/record.url?scp=84908542518&partnerID=8YFLogxK

U2 - 10.1007/s00204-014-1386-4

DO - 10.1007/s00204-014-1386-4

M3 - Article

VL - 88

SP - 2213

EP - 2232

JO - Archives of Toxicology

JF - Archives of Toxicology

SN - 0340-5761

IS - 12

ER -